The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barone, K. S.
Right arrow Articles by Michael, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barone, K. S.
Right arrow Articles by Michael, J. G.
The Journal of Immunology, 1998, 161: 154-160.
Copyright © 1998 by The American Association of Immunologists

Induction of Oral Tolerance in TGF-ß1 Null Mice1

K. Siobhan Barone2,*, Dana D. Tolarova{dagger}, Ilona Ormsby{dagger}, Thomas Doetschman{dagger} and J. Gabriel Michael{dagger}

* Department of Biology, Thomas More College, Crestview Hills, KY 41017; {dagger} Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH 45267

Previous studies have suggested that oral tolerance induction by low doses of Ag is mediated by inhibitory cytokines, particularly TGF-ß1. To examine the roles of TGF-ß1 and other inhibitory cytokines in the induction of oral tolerance, TGF-ß1 null mice and controls were gavaged with 10 to 20 mg (high dose) or 1 mg (low dose) of OVA for 3 days. After immunization with OVA, the in vitro proliferative response of OVA-specific popliteal lymph node cells was assessed. Lymphocytes from all TGF-ß1 null mice fed high doses of OVA exhibited highly significant suppression compared with controls. A weaker, but still significant, suppression was observed in lymphocytes from the majority of TGF-ß1 null mice fed low doses of OVA. In addition, supernatants from these lymphocytes exhibited lower levels of IL-4, IL-10, and IFN-{gamma} than those from water-fed control animals. These results indicate that while TGF-ß1 may play a role in suppression, inhibitory cytokines are not the exclusive mechanism by which low dose oral tolerance is induced.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
M.-L. Cheng, H.-W. Chen, J.-P. Tsai, Y.-P. Lee, Y.-C. Shih, C.-M. Chang, and C.-C. Ting
Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}
J. Leukoc. Biol., May 1, 2006; 79(5): 1033 - 1042.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y. Chung, S.-H. Lee, D.-H. Kim, and C.-Y. Kang
Complementary role of CD4+CD25+ regulatory T cells and TGF-{beta} in oral tolerance
J. Leukoc. Biol., June 1, 2005; 77(6): 906 - 913.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Bommireddy, V. Saxena, I. Ormsby, M. Yin, G. P. Boivin, G. F. Babcock, R. R. Singh, and T. Doetschman
TGF-{beta}1 Regulates Lymphocyte Homeostasis by Preventing Activation and Subsequent Apoptosis of Peripheral Lymphocytes
J. Immunol., May 1, 2003; 170(9): 4612 - 4622.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Bommireddy, I. Ormsby, M. Yin, G. P. Boivin, G. F. Babcock, and T. Doetschman
TGF{beta}1 Inhibits Ca2+-Calcineurin-Mediated Activation in Thymocytes
J. Immunol., April 1, 2003; 170(7): 3645 - 3652.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Finamore, M. Roselli, N. Merendino, F. Nobili, F. Vignolini, and E. Mengheri
Zinc Deficiency Suppresses the Development of Oral Tolerance in Rats
J. Nutr., January 1, 2003; 133(1): 191 - 198.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Kaya, K. M. Dohmen, Y. Wang, J. Schlichting, M. Afanasyeva, F. Leuschner, and N. R. Rose
Cutting Edge: A Critical Role for IL-10 in Induction of Nasal Tolerance in Experimental Autoimmune Myocarditis
J. Immunol., February 15, 2002; 168(4): 1552 - 1556.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Terui, K. Sano, H. Shirota, N. Kunikata, M. Ozawa, M. Okada, M. Honda, G. Tamura, and H. Tagami
TGF-{beta}-Producing CD4+ Mediastinal Lymph Node Cells Obtained from Mice Tracheally Tolerized to Ovalbumin (OVA) Suppress Both Th1- and Th2-Induced Cutaneous Inflammatory Responses to OVA by Different Mechanisms
J. Immunol., October 1, 2001; 167(7): 3661 - 3667.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
P. L. Ogra, H. Faden, and R. C. Welliver
Vaccination Strategies for Mucosal Immune Responses
Clin. Microbiol. Rev., April 1, 2001; 14(2): 430 - 445.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Wang, M. Afanasyeva, S. L. Hill, Z. Kaya, and N. R. Rose
Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1992 - 1999.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. M. SMITH, A. D. EATON, L. M. FINLAYSON, and P. GARSIDE
Oral Tolerance
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): S175 - 178.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. C. Tsitoura, R. H. DeKruyff, J. R. Lamb, and D. T. Umetsu
Intranasal Exposure to Protein Antigen Induces Immunological Tolerance Mediated by Functionally Disabled CD4+ T Cells
J. Immunol., September 1, 1999; 163(5): 2592 - 2600.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Benson, S. S. Stuckman, K. L. Cox, R. M. Wardrop, I. E. Gienapp, A. H. Cross, J. L. Trotter, and C. C. Whitacre
Oral Administration of Myelin Basic Protein Is Superior to Myelin in Suppressing Established Relapsing Experimental Autoimmune Encephalomyelitis
J. Immunol., May 15, 1999; 162(10): 6247 - 6254.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-N. Kweon, K. Fujihashi, Y. Wakatsuki, T. Koga, M. Yamamoto, J. R. McGhee, and H. Kiyono
Mucosally Induced Systemic T Cell Unresponsiveness to Ovalbumin Requires CD40 Ligand-CD40 Interactions
J. Immunol., February 15, 1999; 162(4): 1904 - 1909.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.